Sign In

Geoffrey Parker

Chief Financial Officer, Allogene Therapeutics

Geoffrey Parker is the Executive Vice President and Chief Financial Officer (CFO) at Allogene Therapeutics, a biotechnology company focused on developing allogeneic CAR T cell therapies for cancer. He joined Allogene in October 2023, bringing nearly 40 years of experience in finance and business development within the biotechnology and healthcare sectors.135

Professional Background

  • Allogene Therapeutics: As CFO, Parker oversees financial operations and business strategy. He plays a key role in advancing the company's pipeline of cancer therapies.14
  • Tricida, Inc.: Previously served as Chief Operating Officer, CFO, and Executive Vice President until June 2023, focusing on therapies for chronic kidney disease.13
  • Anacor Pharmaceuticals: Held the position of CFO and Executive Vice President, leading the company through its IPO and eventual $5.2 billion acquisition by Pfizer.13
  • Goldman Sachs: Spent over a decade as Managing Director, leading the West Coast Healthcare Investment Banking group and executing transactions exceeding $100 billion.35

Board Memberships

Parker serves on the boards of:

  • Better Therapeutics (since 2021)
  • Perrigo Company plc (since 2016).23

Education

He holds a Bachelor’s degree in Economics and Engineering Sciences from Dartmouth College and an MBA from Stanford Graduate School of Business.15

Parker is recognized for his expertise in strategic financial management, equity financing, IPOs, and mergers and acquisitions, making him a significant asset to Allogene Therapeutics during its growth phase.14

Highlights

Jul 11 · linkedin

As a Board member I have witnessed first-hand the passion, dedication and commitment the team has demonstrated over the years and today it pays off with the exciting announcement of FDA authorization. This regulatory milestone is a major advancement in the field of diabetes management and I can’t wait to see the impact AspyreRx will have on the millions of patients living with Type 2 Diabetes. Congratulations to Better Therapeutics and CEO Frank Karbe!

Related Questions

What are Geoffrey Parker's key achievements at Allogene Therapeutics?
How did Geoffrey Parker's role at Tricida, Inc. prepare him for his position at Allogene?
What is Geoffrey Parker's educational background and how has it influenced his career?
How has Geoffrey Parker's experience at Goldman Sachs impacted his leadership style?
What are the main challenges Geoffrey Parker has faced in his career in biotechnology?
Geoffrey Parker
Geoffrey Parker, photo 1
Geoffrey Parker, photo 2
Add to my network

Location

San Francisco Bay Area